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ABSTRACT 
Objective: Lung cancer is mostly found in cigarette smokers. Nicotine Acetyl-CoA receptor (nAChR) is found to be responsible for this cancerous 
activity. When cigarette containing nicotine binds with this receptor of lung cells the carcinogenic activity is initiated. Hence, there is a possibility 
for the prevention of lung cancer formation when the nicotine is competitively inhibited by an interfering molecule preferably from natural 
products. This will add additional support in the management of lung cancer. This study was planned to identify the natural compounds which have 
more affinity to the nicotine Acetyl-CoA receptor (nAChR) than the nicotine by in silico evaluation using Auto dock software.  
Methods: About six compounds were subjected and proved with preclinical studies were obtained from a literature survey and were computed for 
docking and characterization.  
Results: Results showed that Taxol had minimum energy level of -11.54 kcal/mol to the nicotine Acetyl-CoA receptor (nAChR) compared to the 
nicotine energy level of -7.01. Other molecules are having the activity in the following order Combretastatins 
Conclusion: It is concluded that these data may be useful for the preparation of different combinations and formulations for the management of 
lung cancer. 
< Camptothecin < Liriodenine < 
Curcumin and Podophyllotoxin < Taxol.  
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INTRODUCTION  
Lung cancer is referred as bronchiogenic cancer or bronchiogenic 
carcinoma. There are two major forms of lung cancer, small cell lung 
cancer and non-small cell lung cancer. Both of these cancers arise 
from the epithelial cells that line the airways of the lungs.  
 
 
Fig. 1: Model of cholinergic signaling in SCC. Exogenous nicotine 
activates MAPK and an Akt proliferative pathway through 
nicotinic cholinergic receptors. Endogenous ACh similarly 
activates both MAPK and Akt pathways through both 
muscarinic and nicotinic receptors. Thus, muscarinic 
antagonists have potential to block proliferation induced both 
by exogenous nicotine and endogenous Ach as well as 
antagonizing the up-regulation in cholinergic signaling induced 
by nicotine (Pingfang et al. 2008). 
Among these two types non-small lung cell cancer is mostly found in 
cigarette smokers [1, 2]. Based on this fact a study was planned with 
some plant based molecule like Combretastatins, Camptothecin
Combretastatin A-4 (CA-4) analogues are biaryls connected by an 
ethylene bridge and have excellent antitumoral and antivascular 
activities, hence it has attracted considerable interest among 
medicinal chemists [5]. The microtubule destabilising agents, 
combretastatin-A-4 (CA-4) led to microtubular array 
disorganization, arrest in mitosis and abnormal metaphases, 
accompanied by the presence of numerous centrosome-independent 
star-like structures containing tubulin and aggregates of 
pericentrosomal matrix components like γ-tubulin, pericentrin and 
ninein, whereas the structural integrity of centrioles was not 
affected by treatment [6]. 
, 
Liriodenine, Curcumin, Podophyllotoxin and Taxol for anticancer 
activity screening against nicotine Acetyl-CoA receptor (nAChR) 
responsible cancer induction [3,4]. The list of molecules selected for 
the study and their properties related to the aim of this study was 
chosen by literature review and listed here. 
Camptothecin is a cytotoxic alkaloid made up of a pentacyclic ring 
structure which contains a pyrrole (3, 4 β) quinoline moiety 
possessing strong anticancer activity and it is isolated mainly from 
the bark and stem of Chinese ornamental tree, Camptotheca 
acuminate. These analogs work by inhibiting DNA topoisomerase I 
which play a major role in various DNA functions like replication 
and transcription [7]. 
Liriodenine is an apomorphine alkaloid belongs to H-Benzo (G)-1,3-
benzodioxolo (6,5,4-dequinolin-8-one) class of isoquinoline alkaloid 
of aporphine subgroup, it can intercalate into the neighboring base 
pairs of DNA double helix, to which its significant antitumor activity 
can be typically attributed. Therefore, it also catalytically inhibits 
topoisomerase to block DNA synthesis. Moreover, it also catalytically 
inhibits topoisomerase to block DNA synthesis and increase p53 and 
iNOS expression to induce cell cycle G1 arrest [8].  
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Curcumin (diferuloylmethane) is a polyphenolic compound isolated 
from the Indian plant spice, Curcuma longa. It finds its application as 
potent anti-cancer compounds. The anti-carcinogenic effects 
induced by curcumin in cancer cells are mediated via the modulation 
of multiple oncogenic signaling transduction elements [9]. Potential 
mechanisms of anti-carcinogenic effects induced by curcumin in 
cancer cells include the down-regulation of the epidermal growth 
factor receptor (EGFR) family members (EGFR/erbB1 and 
erbB2/HER2) insulin-like growth factor type-1 receptor (IGF-1R), 
sonic hedgehog (SHH/GLIs) and Wnt/b-catenin and their 
downstream signaling effectors [10]. 
Podophyllotoxin is derived from the roots of Podophyllum species, to 
be specific, Podophyllum peltatum Linnaeus and Podophyllum emodi 
Wallich. It is a naturally occurring lignan with important 
antineoplastic and antiviral properties [11]. A TOP-53 derivative of 
podophyllotoxin exhibited twice the inhibitory activity of eto-poside 
(VI'-16) against topoisomerase II and induced DNA strand breaks 
but showed no inhibitory activity against tubulin polymerization. 
Taxol is a natural product with significant antitumor activity, has 
been approved for the treatment of breast, ovarian, and lung 
carcinomas. It exhibits marked anti-tumour activity against a broad 
range of rodent tumors [12, 13].  
The major cellular target for Taxol is the tubulin / microtubule 
system of the cancer cell. Taxol has a specific binding site on the 
microtubule and incubation of cells with Taxol causes the formation 
of stable bundles of microtubules that disrupt the normal 
polymerization/depolymerization cycle of microtubules and 
suppresses microtubule dynamics [14].  
Lung cancer is mostly found in cigarette smokers. Nicotine Acetyl-
CoA receptor (nAChR) is found to be responsible for this cancerous 
activity. When cigarette containing nicotine binds with this receptor 
of lung cells the carcinogenic activity is initiated [15, 16, 17]. Hence, 
there is a possibility for the prevention of lung cancer formation 
when the nicotine is competitively inhibited by an interfering 
molecule preferably from natural products. Herbal medicines 
usually act on many targets because of their multiple interaction 
sites [Figure 1: Ping fang Song et al., 2008]. Bioinformatics-based 
methodologies offer alternative approaches and have the potential 
to cut costs in identifying drug targets [18, 19]. In this point of view, 
In silico screening of anticancer activity for the above identified 
molecules with nicotine Acetyl-CoA receptor (nAChR) was 
performed [20, 21]. 
MATERIALS AND METHODS 
Materials  
Plant derivatives and analogs were selected for the present study. 
Ligands selected for In silico docking studies are combretastatins, 
liriodenine, campothecin, podophyllotoxin, curcumin and Taxol. The 
sources used for data base collection include Drugbank, PubChem 
and RCSB protein data bank (PDB). The chemical structures from the 
collected data sources are drawn using chemskecth software (10.1) 
Fig. 2 (2a, 2b, 2c, 2d, 2e and 2f) and Auto Dock 4.2.5 is used for 
effective protein-ligand docking.  
Protein preparation and optimization 
The crystal structure of nicotine Acetyl-CoA receptor (nAChR) used 
in this study was retrieved from RCSB protein data bank (http: 
//www. rcsb. org/pdb). 
Ligand preparation and optimization  
Using Chemsketch Software the structures of the drugs and analogs 
were sketched and generated into MOL File which results in 
subsequent generation of their 3-D structures. These structures are 
viewed using web lab viewer tool which is a molecule format 
converter in PDB. After Ligands preparation optimization was 
carried out using Auto Dock 4.2.5 [10].  
Docking stimulation 
The docking analysis of receptor and their analogs with nicotine 
Acetyl-CoA receptor (nAChR) were carried out by Auto Dock 
docking software 4.2.5. 
RESULT AND DISCUSSION 
The docking of nicotine Acetyl-CoA receptor (nAChR) and the 
conventional drug Combretastatins
Ligands 
, Camptothecin, Liriodenine, 
Curcumin, Podophyllotoxin, Taxol and reference drug Nicotine were 
given in (Figure 3 (a,b,c,d,e and f) and 3A) and Table 1. 
 
Table 1: Represents the binding site of the six different ligands 
with single protein. 
Binding site 
combrestatins Gln 208 N – H – O 2.7 A 
Campothecin N – H – O Val 1023 = 3.4 A 
Arg 1031 NH2 – H – O = 3.0 A 
Arg 1031 NH1 – H – O = 2.4 A 
Curcumin Arg 977 NH2 – H – O = 2.7 A 
Arg 977 NE – H – O = 2.7 A 
Liriodenine No Interactions 
podophyllotoxins Ser 424 O – H – O = 3.2 A 
Ser 424 CB – H – O = 3.3 A 
Thr 281 N – H – O = 2.9 A 
Taxol Asp 696 OD2 – H – H = 1.9 A 
 
The Protein-ligand interaction plays a significant role in structure 
based drug designing. Structure of ligands were drawn by 
Chemsketch and docked with the active site of receptor protein one 
by one. Docking scores obtained from Auto Dock 4.2.5 for nicotine 
Acetyl-CoA receptor (nAChR) and with various ligands 
(Combretastatins
 
, Camptothecin, Liriodenine, Curcumin, 
Podophyllotoxin and Taxol) selected from the in vitro experimental 
evidences indicating possibility for anti-cancer activity (Scores: ΔG 
kcal/mol) were -6.06, -9.85, -10.96 -8.78, -9.36 and -11.54 kcal/mol 
respectively. The reference drug Nicotine showed binding energy 
(ΔG) -7.01 kcal/mol Table 2. 
Table 2: Represents energy value of all phytocompounds. The result positive and negative indicate the possiblity for the anticancer 
activity of compounds. These are arrived based on the relativity observed from the free energy values between phytocompounds and 
reference drug nicotine. 
Protein Free energy value [kcal/mol] Result 
Nicotine  -7.01 Ref Drug 
Taxol -11.54 Positive 
Liriodenine -10.96 Positive 
Campothecin -9.85 Positive 
Podophyllotoxin -9.36 Positive 
Curcumin -8.78 Positive 
-6.06 Combretastatins Negative 
Nicotine has the higher energy than Taxol. Hence, Taxol could block the activity of nicotine and prevent nicotine inducible cancer. Study shows that 
combrestatins is a ligand which has higher ΔG (-6.06 kcal/mol) than the nicotine as well as other ligands that denotes that it is not suitable 
therapeutically purpose. 
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Fig. 2: (a) Combretastatins (b) Campothecin (c) Liriodenine (d) Curcumin (e) Podophyllotoxin (f) Taxol 
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Fig. 3A: (Reference drug Nicotine) 
 
CONCLUSION 
This study concludes that Taxol has very low binding energy than 
the other ligands as well as with reference drug (Nicotine). Hence it 
may be a best choice for lung cancer treatment. Other drugs selected 
for this study having lesser binding energy than the Nicotine may 
also be considered based on other factors like solubility, toxicity, 
possibility for synthesis and so on. 
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